Performance of CURB-65, PSI, and APACHE-II for predicting COVID-19 pneumonia severity and mortality

No prognostic tools for the prediction of COVID-19 pneumonia severity and mortality are available. We explored whether CURB-65, PSI, APACHE-II could predict mortality. included 167 patients with confirmed in this retrospective study. The 30-day were predicted using scales. Kappa test was performed to compare consistency three There a significant difference distribution scores scales ( P < 0.001). Patients PSI class ⩽III, CURB-65 ⩽1, APACHE-II-I all survived. ROC analysis showed areas under curve 0.83 (95% CI, 0.74–0.93), 0.80 0.69–0.90), 0.75–0.92), respectively. Our findings suggest that might be useful pneumonia.